HER2 Gene Protein Assay: A Robust Tool for Evaluating HER2 Status and Intratumoral Heterogeneity in Endometrial Cancers

CONCLUSIONS: HER2 GPA can be used to accurately determine HER2 status in endometrial cancers and is a highly valuable tool for identifying HER2 heterogeneity.PMID:36857635 | DOI:10.1093/ajcp/aqac179

Source: Clinical Genitourinary Cancer - March 1, 2023 Category: Cancer & Oncology Authors: Saba Shafi Hiroaki Nitta Manan Shah Bindu Challa Anil V Parwani Zaibo Li Source Type: research